Skip to main content

Synthesis of Hemiindigoids As Photoswitchable Entities: a Spatiotemporal Handling of Inhibition For Tyrosinase

DPM & DCM

thèse leticia

The project enabled the development of new series of hemi-indigoid compounds targeting two distinct applications. In the first line of research, three successive generations of human tyrosinase inhibitors were synthesized, yielding over one hun-dred distinct compounds. These inhibitors demonstrated sub-micromolar activity and exhibited enhanced efficacy in cellular models, highlighting their potential for therapeutic applica-tions. In the second line of work, eight photoswitchable hemi-indigoid derivatives were designed and synthesized as the first reported photopharmacological compounds of this class. These compounds functioned as acetylcholinesterase inhibitors, of-fering a novel approach for visible-light-controlled modulation of enzyme activity. Together, these efforts underscore the versatility of hemiindigoid scaffolds for both enzymatic inhibi-tion and photopharmacological applications.

L. M. Lazinski, G. Royal, M. Robin, M. Maresca, R. Haudecoeur. J. Med. Chem. 2022, 65, 12594–12625

B. Roulier, I. Rush, L. M. Lazinski, B. Pérès, H. Olleik, G. Royal, A. Fishman, M. Maresca, R. Haudecoeur. Eur. J. Med. Chem. 2023, 246, 114972.

M. Beaumet, L. M. Lazinski, M. Maresca, R. Haudecoeur. Eur. J. Med. Chem. 2023, 259, 115672.

L. M. Lazinski, M. Beaumet, B. Roulier, R. Gay, G. Royal, M. Maresca, R. Haudecoeur. Eur. J. Med. Chem. 2024, 266, 116165.

M. Beaumet, L. M. Lazinski, M. Maresca, R. Haudecoeur. ChemMedChem 2024, 19, e202400314.

L. M. Lazinski, M. Beaumet, F. Loiseau, C. Goudet, M. Boggio-Pasqua, G. Royal, R. Haudecoeur. ChemistryEurope 2025, 3, e202500221.

M. Beaumet, L. M. Lazinski, B. Roulier, G. Royal, M. Maresca, R. Haudecoeur. Submitted.

Arcane PhD student

Leticia da Mata LAZINSKI CIVIL

Supervisors

Romain HAUDECOEUR (DPM) & Guy ROYAL (DCM)

Submitted on December 18, 2025

Updated on December 18, 2025